Mariko Ishibashi
- Oncology top 10%
- Hematology top 5%
- Molecular Biology
- Immunology top 10%
- Pathology and Forensic Medicine
- Co-authors
- Hideto TamuraKoiti InokuchiNamiko OkuyamaKoji TamadaMariko EsumiHidemi TakahashiKíyoyuki OgataTakaji Wakita
- Topics
- Multiple Myeloma Research and Treatments (16 papers)Protein Degradation and Inhibitors (7 papers)Peptidase Inhibition and Analysis (7 papers)
- Cited by
- HematologyImmunologyOncology
- Journals
- BloodHepatologyOncogene
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Mariko Ishibashi
33 papers receiving 742 citations
Peers
Comparison fields: 5 of 67
- Oncology 322
- Hematology 309
- Molecular Biology 297
- Immunology 282
- Pathology and Forensic Medicine 77
Countries citing papers authored by Mariko Ishibashi
This map shows the geographic impact of Mariko Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Ishibashi more than expected).
Fields of papers citing papers by Mariko Ishibashi
This network shows the impact of papers produced by Mariko Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Ishibashi. The network helps show where Mariko Ishibashi may publish in the future.
Co-authorship network of co-authors of Mariko Ishibashi
This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Ishibashi. A scholar is included among the top collaborators of Mariko Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Ishibashi. Mariko Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 78 | |
| 11 | 32 | |
| 12 | 3 | |
| 13 | 41 | |
| 14 | 12 | |
| 15 | 191 | |
| 16 | 15 | |
| 17 | 44 | |
| 18 | 20 | |
| 19 | 86 | |
| 20 | 3 |
About Mariko Ishibashi
Mariko Ishibashi is a scholar working on Hematology, Immunology and Hepatology, having authored 36 papers that have together received 748 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Hematology (309 citations), Immunology (282 citations) and Oncology (322 citations). Mariko Ishibashi has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Hideto Tamura, Koiti Inokuchi, Namiko Okuyama, Koji Tamada, Mariko Esumi, Hidemi Takahashi, Kíyoyuki Ogata, Takaji Wakita, Sakae Tanosaki and Asaka Kondo. Their work appears in journals such as Blood, Hepatology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.